(Q57628870)
English
Rationale and design of the GISSI-Atrial Fibrillation trial: a randomized, prospective, multicentre study on the use of valsartan, an angiotensin II AT1-receptor blocker, in the prevention of atrial fibrillation recurrence
article by Marcello Disertori et al published January 2006 in Journal of Cardiovascular Medicine
Statements
Rationale and design of the GISSI-Atrial Fibrillation trial: a randomized, prospective, multicentre study on the use of valsartan, an angiotensin II AT1-receptor blocker, in the prevention of atrial fibrillation recurrence (English)
0 references
January 2006
0 references
7
0 references
29-38
0 references
1
0 references